Quick Search

 

 


 

 

Result Summary for 101468/199

Result Summary
Protocol ID: 101468/199
Clinical Study ID: 101468/199
Official Title: An open label study conducted in healthy volunteers to characterize the pharmacokinetics of a new unmarketed formulation of ropinirole
Phase: Phase 1
Study Indications or Diseases:
  • Restless Legs Syndrome
Generic Name: ropinirole
Trade/Product Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.